Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Wei
Timothy D Henry

Showing results (511-520 of 754) with videos related to

Pageof 76
Sort By:
Circulation|March 19, 2003
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular AngiogenesisTimothy D Henry, Brian H Annex, George R McKendall, et al.
American Heart Journal|December 6, 2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationaleClaudia Zierold, Marjorie A Carlson, Udo C Obodo, et al.
Scientific Reports|July 2, 2017
Circulating Biomarkers to Identify Responders in Cardiac Cell therapyJesse V Jokerst, Nicholas Cauwenberghs, Tatiana Kuznetsova, et al.
JACC. Cardiovascular Interventions|July 4, 2016
The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES StudySorin J Brener, Ajay J Kirtane, Thomas D Stuckey, et al.
Journal of the American Heart Association|January 21, 2020
Prehospital Activation of Hospital Resources (PreAct) ST-Segment-Elevation Myocardial Infarction (STEMI): A Standardized Approach to Prehospital Activation and Direct to the Catheterization Laboratory for STEMI Recommendations From the American Heart Association's Mission: Lifeline ProgramMichael C Kontos, Michael R Gunderson, Jessica K Zegre-Hemsey, et al.
European Heart Journal|January 10, 2018
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trialsTimothy D Henry, Douglas W Losordo, Jay H Traverse, et al.
Circulation. Cardiovascular Quality and Outcomes|April 30, 2025
2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance MeasuresMarlene S Williams, Glenn N Levine, Dinesh Kalra, et al.
Journal of the American College of Cardiology|May 1, 2025
2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance MeasuresMarlene S Williams, Glenn N Levine, Dinesh Kalra, et al.
Medrxiv : the Preprint Server for Health Sciences|February 17, 2023
Characteristics and Long-term Mortality in Patients with ST-Segment Elevation Myocardial Infarction with Non-Obstructive Coronary Arteries (STE-MINOCA): A High Risk CohortOdayme Quesada, Mehmet Yildiz, Timothy D Henry, et al.
Transgender Health|November 22, 2017
Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective?Michael D Nelson, Lidia S Szczepaniak, Janet Wei, et al.
Pageof 76

Showing results (511-520 of 754) with videos related to

Sort By:
Pageof 76
Circulation|March 19, 2003
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular AngiogenesisTimothy D Henry, Brian H Annex, George R McKendall, et al.
American Heart Journal|December 6, 2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationaleClaudia Zierold, Marjorie A Carlson, Udo C Obodo, et al.
Scientific Reports|July 2, 2017
Circulating Biomarkers to Identify Responders in Cardiac Cell therapyJesse V Jokerst, Nicholas Cauwenberghs, Tatiana Kuznetsova, et al.
JACC. Cardiovascular Interventions|July 4, 2016
The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES StudySorin J Brener, Ajay J Kirtane, Thomas D Stuckey, et al.
Journal of the American Heart Association|January 21, 2020
Prehospital Activation of Hospital Resources (PreAct) ST-Segment-Elevation Myocardial Infarction (STEMI): A Standardized Approach to Prehospital Activation and Direct to the Catheterization Laboratory for STEMI Recommendations From the American Heart Association's Mission: Lifeline ProgramMichael C Kontos, Michael R Gunderson, Jessica K Zegre-Hemsey, et al.
European Heart Journal|January 10, 2018
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trialsTimothy D Henry, Douglas W Losordo, Jay H Traverse, et al.
Circulation. Cardiovascular Quality and Outcomes|April 30, 2025
2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance MeasuresMarlene S Williams, Glenn N Levine, Dinesh Kalra, et al.
Journal of the American College of Cardiology|May 1, 2025
2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance MeasuresMarlene S Williams, Glenn N Levine, Dinesh Kalra, et al.
Medrxiv : the Preprint Server for Health Sciences|February 17, 2023
Characteristics and Long-term Mortality in Patients with ST-Segment Elevation Myocardial Infarction with Non-Obstructive Coronary Arteries (STE-MINOCA): A High Risk CohortOdayme Quesada, Mehmet Yildiz, Timothy D Henry, et al.
Transgender Health|November 22, 2017
Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective?Michael D Nelson, Lidia S Szczepaniak, Janet Wei, et al.
Pageof 76